Percentage of individuals at least 18 years of age as of the beginning of the performance period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the performance period.
Specialty: Internal Medicine
Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug Users
Percentage of patients, regardless of age, who are active injection drug users who received screening for HCV infection within the 12-month reporting period.
Depression Remission at Twelve Months
The percentage of adolescent patients 12 to 17 years of age and adult patients 18 years of age or older with major depression or dysthymia who reached remission 12 months (+/- 60 days) after an index event date.
Closing the Referral Loop: Receipt of Specialist Report
Percentage of patients with referrals, regardless of age, for which the referring clinician receives a report from the clinician to whom the patient was referred.
Functional Status Assessments for Heart Failure
Percentage of patients 18 years of age and older with heart failure who completed initial and follow-up patient-reported functional status assessments.
HIV Viral Suppression
Percentage of patients, regardless of age, diagnosed with HIV prior to or during the first 90 days of the performance period, with an eligible encounter in the first 240 days of the performance period, whose last HIV viral load test result was less than 200 copies/mL during the performance period.
Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:* Women age 21-64 who had cervical cytology performed within the last 3 years* Women age 30-64 who had cervical human papillomavirus (HPV) testing performed within the last 5 years
Falls: Screening for Future Fall Risk
Percentage of patients 65 years of age and older who were screened for future fall risk during the measurement period.
CAHPS for MIPs Clinician/Group Survey
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) for MIPS Clinician/Group Survey is comprised of 10 Summary Survey Measures (SSMs) and measures patient experience of care within a group practice. The CBE endorsement status and endorsement id (if applicable) for each SSM utilized in this measure are as follows:
• Getting Timely Care, Appointments, and Information; (Not endorsed by CBE)
• How well Providers Communicate; (Not endorsed by CBE)
• Patient’s Rating of Provider; (CBE endorsed # 0005)
• Access to Specialists; (Not endorsed by CBE)
• Health Promotion and Education; (Not endorsed by CBE)
• Shared Decision-Making; (Not endorsed by CBE)
• Health Status and Functional Status; (Not endorsed by CBE)
• Courteous and Helpful Office Staff; (CBE endorsed # 0005)
• Care Coordination; (Not endorsed by CBE)
• Stewardship of Patient Resources. (Not endorsed by CBE)
Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy
Percentage of patients aged 18 years and older with atrial fibrillation (AF) or atrial flutter who were prescribed an FDA-approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period.